Case Study: Albany Capital reduces operational risk, lowers costs, and speeds time-to-market with Enfusion

Enfusion’s multi-asset class coverage and client-first approach reduced operational risk, cost, and time to market for Albany Capital’s launch and beyond

Albany Capital, a Sydney-based global macro hedge fund preparing to launch in early 2020, faced COVID delays and a complex operating decision: whether to stitch together multiple best-of-breed systems or adopt a single platform that could handle multi-asset trading, derivatives, and straight-through automation. To avoid high total cost of ownership and operational workarounds, Albany evaluated and selected Enfusion’s front-to-back solution—using Enfusion’s Portfolio Management System, Order and Execution Management System, and Accounting—to provide a unified technology foundation.

Enfusion consolidated Albany’s PMS, OEMS, and accounting into a single source of truth, enabling straight-through processing, reducing operational and institutional risk, and lowering TCO. The firm launched in May 2021 with reliable, error-free P&Ls and execution checks (Albany reported no P&L or execution errors in shadow runs), saved on headcount through Enfusion’s client-first support, and gained scalability—adding a London trader to extend trading hours—while materially speeding time-to-market and simplifying ongoing operations.

Albany Capital

Alastair Sloan

Chief Investment Officer